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Abstract 
Local estimates of HIV-prevalence provide information that can be used to target interventions 
and consequently increase the efficiency of the resources. This closer-to-optimal allocation can 
lead to better health outcomes, including the control of the disease spread, and for more people. 
Producing reliable estimates at smaller geographical levels can be challenging and careful 
consideration of the nature of the data and the epidemiologic rational is needed. In this paper, 
we use the DHS data phase V to estimate HIV prevalence at the first-subnational level in 
Kenya, Tanzania, and Mozambique. We fit the data to a spatial random effect intrinsic 
conditional autoregressive (ICAR) model to smooth the outcome. We also use a sampling 
specification from a multistage cluster design. We found that Nyanza (P=14.2%) and Nairobi 
(P=7.8%) in Kenya, Iringa (P=16.2%) and Dar es Salaam (P=10.1%) in Tanzania, and Gaza 
(P=13.7%) and Maputo City (P=12.7%) in Mozambique are the regions with the highest 
prevalence of HIV, within country. Our results are based on statistically rigorous methods that 
allowed us to obtain an accurate visual representation of the HIV prevalence in the subset of 
African countries we chose. These results can help in identification and targeting of high-
prevalent regions to increase the supply of healthcare services to reduce the spread of the 
disease and increase the health quality of people living with HIV.  
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Introduction 
The most important challenge for Eastern and Southern Africa to achieve the 90-90-90 HIV 
targets are initiation and retention to treatment.1 The lack of resources to provide appropriate 
care to all people living with HIV (PLWI) limits the proportion of people that can achieve viral 
suppression which in turn increases the opportunity for disease spread.2,3 Thus, it is essential to 
find ways to increase resources’ efficiency, in order to obtain the best possible health outcomes 
at the lowest investment. One way to achieve this is by improving intervention’s targeting across 
geographical areas,4 which requires reliable information at local level to guide policy decisions. 
In the context of initiation and retention to care, observing the prevalence – defined as the 
proportion of HIV positive people in a given region geographic, demographic and temporally 
defined – at a sub-national level could provide means to guide resources-allocation decisions.  
The main issue with prevalence mapping is that estimations across sub-national regions are 
needed to obtain better information but are usually based on incomplete survey data. Therefore, 
if no cases are recorded in a particular region, the empirical prevalence would be zero, but not 
the hypothetical one, which is the one we are interested. Hence, we recognize information is 
incomplete (i.e. not all cases have been recorded), and the modelling probability to not belong 
to the total population at-risk. In addition, because no completely-at-random sampling is 
feasible, survey data carries selection bias in the estimations. To account for this, we conduct 
the prevalence mapping using Small Region Estimation (SAE).5,6 
The aim of this study is to estimate the prevalence in a sub-set of Eastern African countries at 
the first sub-national level, to create information relevant for policy-decision making. 
Methods 
Data 
We used the DHS HIV and geospatial data.7 The selected sub-set of countries are neighbor 
countries in Eastern Africa, defined as sharing a border, have important differences in their 
national HIV prevalence estimates, and have HIV and geospatial information in the same phase 
of the DHS Program for sampling design and data collection consistency. We decided for: 
Kenya, Tanzania, and Mozambique. Whose estimated national prevalence for the 15 to 49 
years old population was 5.66%, 3.97%, and 11.98%, respectively in 2017.8,9 This is the most 
heterogeneous cluster, in terms of national HIV-prevalence, in East Africa that we could found. 
All these countries have spatial and HIV data collected in the phase DHS-V, executed between 
2007 and 2009. The prevalence mapping would be conducted over the first administrative sub-
national areas: regions within countries. 
The geospatial information for each country was originally formed by the cluster information and 
the boundaries. The former included the spatial points for all clusters within regions, while the 
latter included the polygons for each region within a country. Using the coordinates of both 
datasets we identified to which region each cluster belonged. Then, we merge the information. 
The HIV data was geographically identified only by clusters. We used the merged spatial 
information to determine to which region, each of the clusters in the HIV data belong to.  
The final spatial dataset is the appended data of the three countries containing the polygons for 
each of the sub-national regions. The final HIV dataset is also the appended data of the three 
countries containing the individual health outcome (HIV positive or negative), the cluster, and 
associated sub-national region. 
Model 
Considering that the DHS survey used a multistage cluster design sampling, we conduct a SAE, 
with a spatial random effect intrinsic conditional autoregressive (ICAR) model10 – the BYM 
model –, for a binary outcome. The random effects model has a higher precision than the direct 
estimation that just considers the sampling design.11 The BYM model allows for an indirect 
estimation, that allows for the use of information across regions, based on defined neighbors, to 
perform the smoothing. A neighbor is a region with a single or multiple shared border. We follow 
the ‘B style’ of weighting to allow places with extra neighbors to have a higher influence on the 
results. Since we treated the sub-set of countries as a unit, the neighbor determination is not 
constrained within the country. Hence, the prevalence estimation borrows information across 
countries. 
The estimated prevalence for each region 𝑃𝑖, where 𝑖 notates each region in the first sub-
national level, follows the model:12 
𝑃𝑖 = 𝑙𝑜𝑔𝑖𝑡(𝑝𝑖) 
𝑌𝑖  ~ 𝑁(𝜃, 𝑉𝑖) 
𝜃𝑖 = 𝛽0 + 𝜖𝑖 + 𝑆𝑖 
𝜖𝑖  ~𝑖𝑖𝑑  𝑁(0, 𝜎𝜖
2) 
𝑆𝑖 ~ 𝐼𝐶𝐴𝑅(𝜎𝑆
2) 
Where, 𝑝𝑖 is the direct (desing-based weighted) estimate of the prevalence for the region 𝑖; 𝑉𝑖 is 
the estimated variance for each region; and 𝛽0 the intercept. This model does not include 
covariates. We perform the analysis using the SUMMER package13 in R.  
Results 
The original dataset, aggregated for the three countries had a sample size of 39,575 
observation (Kenya, n=7,001; Tanzania, n=15,597; Mozambique, n=16,976). After deleting the 
observation containing missing data in the geographic information (no missing values in the HIV 
data), the final sample size was 39,258 (99.2%). Given the small amount of observations 
missing, we did not perform a missing-at-random analysis.  
We found 45 regions in total. The sample size varies highly across these regions, ranging from 
308 to 1,942 observations. (Figure 1) 
 
Fig1. Regions under analysis color-coded by their sample size 
Tanzania is the country with the highest number of regions, 26, and at the same time the 
smallest sample size for each one. Kenya, with 8 regions, and moreover Mozambique, with 11 
regions, have higher associated sample size. 
Figure 2 shows the results of the SAE. The estimated prevalence for all regions ranges from 
7.24% to 15.5%; with a median of 5.13% and a standard deviation (SD) of 0.38. Figure 3 shows 
the point-estimate results for each country. The scale for the color-code is independent for each 
country in Figure 3. 
  
 
Fig 2. Maps of point estimate and 95% credible intervals for the posterior mean of the weighted 
smoothed model 
 
 
Fig 3. Zoom in the HIV-prevalence maps for each country. Kenya in the left, Tanzania in the 
middle, and Mozambique in the right panel  
Our analysis allows us to identify the three regions with the highest prevalence in each country. 
Nyanza (𝑃𝑖=14.2%), Nairobi (𝑃𝑖=7.8%), and Western (𝑃𝑖=6.4%), in Kenya. In Tanzania, Iringa 
(𝑃𝑖=16.2%), Dar es Salaam (𝑃𝑖=10.1%), and Mbeya (𝑃𝑖=9.0%). Finally, in Mozambique, Gaza 
(𝑃𝑖=14.9%), Maputo City (𝑃𝑖=13.7%), and Maputo (region) (𝑃𝑖=12.7%). In Kenya and Tanzania, 
we can observe that the highest prevalence is almost an outlier compared to the rest of the 
country. These results would warrant a prioritization of these regions at a Federal level.  
 
Discussion 
We conducted a HIV-prevalence mapping for a subset of east African countries, with a SAE 
estimation using a BYM model. This approximation has multiple theoretical benefits. First, the 
SAE is consistent with the small sample size that observed in many of the areas under 
estimation. Second, our model acknowledges the sampling design and the associated 
distribution of sampling probabilities. Third, conducts a spatial smoothing process that allows 
the model to borrow information from the neighbors in the estimation of each posterior to 
improve the precision of the estimates, which is particularly helpful in presence of sparse data 
as the DHS’. Our study has an additional advantage because it defines the neighbors beyond 
the country borders, by taking the sub-set of countries as a unit. We believe this was particularly 
useful in the estimation of the prevalence for Tanzania, where all its regions had a small sample 
size.  
Comparative performance of the smoothing process 
We present the difference in performance for the estimation of prevalence at the first-
subnational level, for the weighted model that includes a correction for cluster sampling, and the 
weighted-smooth model that includes a smoothing process for the outcome. 
 
 
Fig 4. Comparison of estimated prevalence (left panel) and standard errors (right panel) 
between the weighted only and weighted and smoothed (SAE) estimates. 
Figure 4 shows that the smoothing process pulled the posterior estimates towards the middle of 
the distribution, increasing the value of the estimates in the lower half, and reducing it for the 
estimates in the higher half. The right-side panel shows that the standard errors created by the 
smoothing analysis tend to be lower in comparison, denoting estimates with higher precision.  
Thus, because the smoothing model estimates each prevalence using the information provided 
by its neighbors, the resulting distribution of prevalence for all regions is less disperse, with the 
extreme values pulled towards the middle. Regarding the neighbors’ definition, there are two 
major style of weighting “B” and “W”. We perform separate analyses with both styles obtaining 
the exact same results for the posteriors and the standard deviation. We decided in favor of the 
B style because in theory it allows for the areas with more neighbors to have more influence in 
the results. Which makes sense when considering that migration is a very important factor in the 
HIV epidemic14, and regions with more borders are more likely to have more migrants. 
 
 
 
Fig 5.  Error bars for the Weighted smoothed (SAE) estimates and the Naïve (direct) ones 
According to Figure 5, even though the weighted only model includes a correction for the 
sampling methodology, the resulting estimates for around 4 regions are still not significantly 
different from zero i.e. estimations whose lower 95%CI bound included zero. This demonstrates 
an important consequence of the smoothing process, the elimination of prevalence non-
statically different from zero. This issue weights on the difference between the observed and the 
empirical prevalence.6 The lack of cases in a given cluster does not mean that there are no 
cases in that geographical area. Hence, surrogating the estimated risk from adjacent areas is 
imperative to estimate a prevalence closer to the real risk of infection for HIV. 
Compared to previous analysis that have mapped the prevalence of HIV15, our results are 
systematically lower. One reason resides in the granularity of the data used by the authors. 
They collected 38,897 data points in 134 seroprevalence survey and sentinel surveillance of 
antenatal care clinics for a total of 46 countries. Moreover, they gathered information for 17 
years. Hence, the analytical process can smooth the estimates across geographic and temporal 
units and provide better estimates. Additionally, the authors calibrated the model using national 
estimations from the Global Burden of Disease16, which provides an additional level of external 
validity but also introduces more bias in the analysis. Nonetheless, the estimated confidence 
intervals for both studies are overlapped in all the cases for which a comparison was possible, 
and more importantly our results are consistent regarding which regions within countries have 
the highest prevalence. 
Limitations 
This study is not without limitations. First, the data that we used was collected between 2007 
and 2009. Hence, the picture that our estimates present is likely outdated considering how fast 
the HIV epidemic variables move over time. We chose the phase DHS-V because that was the 
only phase in which our sub-set of countries had HIV and geospatial information. 
Second, although socioeconomic and demographic variables influence the prevalence of 
HIV17,18 and this variables are likely spatial correlated, our model did not include covariates. The 
main reason is that we did not find a linkage between the HIV data and the individual survey 
from the DHS as well, that contains many of those variables. Further investigation is necessary. 
Strengths 
The objective of this study was to present with reliable information to inform policy decision in 
the context of optimize resources allocation. In that regard, the temporality of the data is not as 
important since the absolute numbers can change by the relative risk is less likely to change or 
even shift over time. 
Second, our methodology is in concordance with both the nature of the data – by including a 
correction due to the sampling design – and the epidemiology rationale – by using a smoothing 
process to limit the probability of having prevalence equal to zero and modeling the outcome in 
each region as part of a bigger area, rather than in isolation.  
Conclusions 
Our results are based on statistically rigorous methods that allowed us to obtain an accurate 
visual representation of the HIV prevalence in the subset of African countries we chose. These 
results can help in identification and targeting of high-prevalent regions to increase the supply of 
healthcare services to reduce the spread of the disease and increase the health quality of 
PLWH.  
This study builds on secondary publicly available data and generates reliable estimates that can 
be used to target interventions. This creates an important opportunity to apply the same 
methodology in other settings, where data might be scarce and resources to supplement data 
collection unavailable. 
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